Tuesday June 19th, 2012
In an extraordinary IDIBAPS Seminar, organized by coordinators of the Translational Medicine Master at UB, Dr. Carlos Fernández-Hernando spoke on June 5th about “microRNAs in vascular diseases and metabolic disease“. He is Professor at the Department of Medicine (Division of Cardiology) and Cell Biology of the Langone Medical Center, University of New York. His work focuses on determining the role of microRNAs in the metabolism of cholesterol and other related cardiovascular diseases. The event was presented by Dr. Manuel Morales, a member of the IDIBAPS Team Physiopathology and treatment of ascites and altered renal function in liver cirrhosis.
Read the rest of this entry »
Monday January 30th, 2012
Time magazine was the first publication to announce its decision to include the malaria vaccine in its New Year list of medical breakthroughs. A few days later, the prestigious scientific journal Science also recognized the advance. Both publications chose the RTS,S malaria vaccine as one of the ten most important scientific advances of 2011. The decision made by these two influential publications reflects the scientific community’s recognition of a vaccine which, despite its moderate effectiveness, nonetheless represents an unprecedented breakthrough in the complex struggle against the parasite that causes over 650,000 deaths a year. The RTS,S vaccine against malaria is a long term research where IDIBAPS – Hospital Clínic International Heath research team played a key role. This research in international health issues became a reference centre called Barcelona Centre for International Health Research (CRESIB), led by Dr. Pedro Alonso.